NCT05582551 Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors Status RECRUITING Phase NA
NCT05552157 A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation Status RECRUITING Phase PHASE2/PHASE3
NCT05541406 Efficacy of a Multi-level School Intervention for LGBTQ Youth Status ACTIVE_NOT_RECRUITING Phase NA
NCT05521984 Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i) Status RECRUITING Phase PHASE1
NCT05483010 Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS) Status RECRUITING Phase PHASE2
NCT05377827 Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies Status SUSPENDED Phase PHASE1
NCT05269394 Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU) Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT05233566 Ketamine for Postoperative Avoidance of Depressive Symptoms: The K-PASS Feasibility Trial Status COMPLETED Phase PHASE3
NCT05124132 Resilience and Brain Health of Older Adults (MEDEX-2) Status ENROLLING_BY_INVITATION Phase NA
NCT05111262 Symptom-driven ICS/LABA Therapy for Patients With Asthma Non-adherent to Daily Maintenance Inhalers Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05057702 Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma Status RECRUITING Phase NA
NCT05030441 Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1 Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05011422 Haploidentical Hematopoietic Stem Cell Transplantation With Ex Vivo TCR Alpha/Beta and CD19 Depletion in Pediatric Hematologic Malignancies Status RECRUITING Phase PHASE1
NCT04996706 Evaluation of Lymphoma Prognosis and Survivorship in Recently Diagnosed Patients, LEO Study Status ENROLLING_BY_INVITATION Phase N/A
NCT04968964 Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing Status RECRUITING Phase NA